Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

http://scihub22266oqcxt.onion/ 9064959!ä!9064959 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Z+Kardiol 1996 ; 85 Suppl 6 (ä): 147-51 Nephropedia Template TP {{tp|p=9064959|t=1996. Magnesium: Aktuelle Studien--kritische Wertung--Konsequenzen |pdf=|usr=}}{{9064959}} gab.com Text Magnesium: Aktuelle Studien--kritische Wertung--Konsequenzen JO: Z Kardiol http://www.kidney.de/pget.php?&tw=1&pmid=9064959 #FOAvip The therapeutic efficacy of magnesium has been studied during recent years in a number of cardiovascular diseases: supraventricular and ventricular arrhythmias (multifocal atrial tachycardia, Torsade de pointes-tachycardia, glycoside-associated arrhythmias, sustained ventricular tachycardia), acute myocardial infarction, heart failure and arterial hypertension. Although only a few of these arrhythmias were studied under controlled conditions, the therapeutic efficacy of intravenous magnesium given in a high dose in these arrhythmias seems to be established. By contrary, the efficacy of magnesium in acute myocardial infarction, congestive heart failure and arterial hypertension remains controversial up to now. Magnesium cannot be regarded as standard therapy for example for patients with acute myocardial infarction. Twit Text FOAVip Magnesium: Aktuelle Studien--kritische Wertung--Konsequenzen ????Z Kardiol http://www.kidney.de/pget.php?&tw=1&pmid=9064959 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=9064959 #FOAvip English Wikipedia <ref>{{Cite pmid|9064959}}</ref> Magnesium: Aktuelle Studien--kritische Wertung--Konsequenzen #MMPMID9064959 Meinertz T Z Kardiol 1996[]; 85 Suppl 6 (ä): 147-51 PMID9064959show ga The therapeutic efficacy of magnesium has been studied during recent years in a number of cardiovascular diseases: supraventricular and ventricular arrhythmias (multifocal atrial tachycardia, Torsade de pointes-tachycardia, glycoside-associated arrhythmias, sustained ventricular tachycardia), acute myocardial infarction, heart failure and arterial hypertension. Although only a few of these arrhythmias were studied under controlled conditions, the therapeutic efficacy of intravenous magnesium given in a high dose in these arrhythmias seems to be established. By contrary, the efficacy of magnesium in acute myocardial infarction, congestive heart failure and arterial hypertension remains controversial up to now. Magnesium cannot be regarded as standard therapy for example for patients with acute myocardial infarction. |Anti-Arrhythmia Agents/*administration & dosage/adverse effects[MESH] |Clinical Trials as Topic[MESH] |Dose-Response Relationship, Drug[MESH] |Electrocardiography/drug effects[MESH] |Heart Conduction System/drug effects/physiopathology[MESH] |Humans[MESH] |Infusions, Intravenous[MESH] |Magnesium/*administration & dosage/adverse effects[MESH] |Myocardial Infarction/complications/drug therapy/physiopathology[MESH] |Tachycardia, Supraventricular/*drug therapy/etiology/physiopathology[MESH]Magnesium: Aktuelle Studien--kritische Wertung--Konsequenzen (epmc).pdf DeepDyve Pubget Overpricing